AQP7 (Aquaporin-7) variants and mutations
AQP7 (also known as Aquaporin-7) is a human protein-coding gene encoding an aquaporin-7 protein. It facilitates glycerol movement across adipocyte and renal membranes and contributes to systemic glycerol and energy metabolism. Genetic variation has been investigated for effects on obesity and metabolic traits, while complete deficiency appears uncommon in humans. This analysis covers 744 AQP7 variants and mutations. Of these, 78% have computational variant effect predictions. Disease context includes lung adenocarcinoma, atopic eczema, and COVID-19. Example AQP7 variants include V2F, V2I, and A4V.
Variant analysis overview
- Gene: AQP7
- Protein: Aquaporin-7
- UniProt accession: O14520
- Organism: Homo sapiens
- Variants analyzed: 744
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 503 unspecified-consequence records; 1 stop retained variant; 88 synonymous variants; 116 missense variants; 20 frameshift variants; 3 stop lost; 3 stop-gained variants; 3 in-frame deletions; 3 splice-region variants; 1 in-frame insertions; 1 substitution
- Prediction scores: 584 variants have prediction scores (78% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: lung adenocarcinoma, atopic eczema, COVID-19, familial idiopathic steroid-resistant nephrotic syndrome, focal segmental glomerulosclerosis, nephrotic syndrome, nephronophthisis, idiopathic hypercalciuria, primary hyperoxaluria type 3, hepatocellular carcinoma, proteinuria, chronic benign, uridine-cytidineuria.
Protein structure and variant hotspots
- Protein features: 6 transmembrane segments; 1 post-translational modification sites.
- Structural context: 246 variants have structural context.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable AQP7 variants
Examples include V2F, V2I, A4V, S5A, G6R, H7N, H7Q, R8K. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- V2F (p.Val2Phe), TOPMed rs1458881244, gnomAD rs1458881244, REVEL 0.20, CADD 0.37
- V2I (p.Val2Ile), TOPMed rs1458881244, gnomAD rs1458881244, REVEL 0.18, CADD 0.01
- A4V (p.Ala4Val), cosmic curated COSV10645, ESP rs143956595, TOPMed rs143956595, gnomAD rs143956595, REVEL 0.14, CADD 0.03
- S5A (p.Ser5Ala), ExAC rs763009579, gnomAD rs763009579, REVEL 0.07, CADD 0.20
- G6R (p.Gly6Arg), 1000Genomes rs148119598, ESP rs148119598, ExAC rs148119598, TOPMed rs148119598, REVEL 0.20, CADD 0.30
- H7N (p.His7Asn), TOPMed rs959914653, gnomAD rs959914653, REVEL 0.12, CADD 7.07
- H7Q (p.His7Gln), 1000Genomes rs374964943, ESP rs374964943, ExAC rs374964943, TOPMed rs374964943, REVEL 0.13, CADD 2.07
- R8K (p.Arg8Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R9P (p.Arg9Pro), ExAC rs776777658, TOPMed rs776777658, gnomAD rs776777658, REVEL 0.30, CADD 25.00
- R9Q (p.Arg9Gln), ExAC rs776777658, TOPMed rs776777658, gnomAD rs776777658, REVEL 0.26, CADD 25.10
- R9W (p.Arg9Trp), rs143724569, 1000Genomes rs143724569, ESP rs143724569, ExAC rs143724569, REVEL 0.29, CADD 17.10, Variant assessed as somatic; moderate impact.
- T11I (p.Thr11Ile), cosmic curated COSV53034, TOPMed rs1308054467, REVEL 0.27, CADD 7.48
- R12C (p.Arg12Cys), rs139297434, cosmic curated COSV53015, UniProt VAR 067253, 1000Genomes rs139297434, REVEL 0.19, CADD 8.66
- R12H (p.Arg12His), ExAC rs777690481, TOPMed rs777690481, gnomAD rs777690481, REVEL 0.16, CADD 5.40
- G13R (p.Gly13Arg), TOPMed rs1825754264, gnomAD rs1825754264
- G13S (p.Gly13Ser), TOPMed rs1825754264, gnomAD rs1825754264, REVEL 0.16, CADD 0.04
- K15E (p.Lys15Glu), ExAC rs758186124, gnomAD rs758186124, REVEL 0.16, CADD 18.40
- M16I (p.Met16Ile), gnomAD rs1421013136, cosmic curated COSV53003, REVEL 0.19, CADD 15.00
- M16T (p.Met16Thr), gnomAD rs201166466, REVEL 0.21, CADD 9.83
- M16V (p.Met16Val), ExAC rs752676074, gnomAD rs752676074, REVEL 0.20, CADD 8.18
- M16W (p.Met16Trp), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- V17I (p.Val17Ile), TOPMed rs1825752966
- W19* (p.Trp19Ter), TOPMed rs1477831537, gnomAD rs1477831537, CADD 23.90
- W19C (p.Trp19Cys), TOPMed rs1477831537, gnomAD rs1477831537, REVEL 0.27, CADD 0.90
- W19S (p.Trp19Ser), 1000Genomes rs185204201, ExAC rs185204201, TOPMed rs185204201, gnomAD rs185204201, REVEL 0.13, CADD 8.34
- V21A (p.Val21Ala), gnomAD rs1450363188, REVEL 0.14, CADD 0.66
- V21M (p.Val21Met), ExAC rs766484596, TOPMed rs766484596, gnomAD rs766484596, REVEL 0.10, CADD 0.02
- I22M (p.Ile22Met), TOPMed rs1206150599, gnomAD rs1206150599, REVEL 0.12, CADD 0.24
- I22T (p.Ile22Thr), gnomAD rs1317523871, REVEL 0.14, CADD 0.31
- I22V (p.Ile22Val), ExAC rs760862357, TOPMed rs760862357, gnomAD rs760862357
- K24T (p.Lys24Thr), Ensembl rs1825750333
- I25N (p.Ile25Asn), ExAC rs750700265, REVEL 0.17, CADD 16.40
- I25V (p.Ile25Val), Ensembl rs1825750109, REVEL 0.06, CADD 1.77
- Q26H (p.Gln26His), ExAC rs767860854, TOPMed rs767860854, gnomAD rs767860854, REVEL 0.23, CADD 0.07
- E27D (p.Glu27Asp), gnomAD rs1232662359, REVEL 0.20, CADD 0.08
- E27K (p.Glu27Lys), 1000Genomes rs145775825, ExAC rs145775825, gnomAD rs145775825, REVEL 0.21, CADD 0.04
- I28M (p.Ile28Met), ExAC rs774787164, gnomAD rs774787164, REVEL 0.20, CADD 0.08
- I28T (p.Ile28Thr), gnomAD rs1341168484
- L29M (p.Leu29Met), ExAC rs2381005, gnomAD rs2381005
- L29P (p.Leu29Pro), 1000Genomes rs192851993, ESP rs192851993, ExAC rs192851993, TOPMed rs192851993, REVEL 0.53, CADD 22.90
- L29V (p.Leu29Val), ExAC rs2381005, gnomAD rs2381005
- Q30L (p.Gln30Leu), NCI-TCGA Cosmic COSV5301, cosmic curated COSV53015, Variant assessed as somatic; moderate impact.
- Q30R (p.Gln30Arg), ExAC rs745617679, REVEL 0.09, CADD 4.46
- R31S (p.Arg31Ser), ExAC rs776252656, TOPMed rs776252656, gnomAD rs776252656, REVEL 0.20, CADD 9.40
- K32N (p.Lys32Asn), TOPMed rs1825745882
- M33L (p.Met33Leu), Ensembl rs1825745685
- V34A (p.Val34Ala), ExAC rs2381004, gnomAD rs2381004, Likely benign
- V34E (p.Val34Glu), rs2381004, cosmic curated COSV53007, ClinVar RCV004557739, ExAC rs2381004, Likely benign, EBV-positive nodal T- and NK-cell lymphoma
- V34M (p.Val34Met), 1000Genomes rs543495409, ExAC rs543495409, gnomAD rs543495409, REVEL 0.22, CADD 16.20
- R35* (p.Arg35Ter), ExAC rs747841241, TOPMed rs747841241, gnomAD rs747841241, CADD 35.00
- R35G (p.Arg35Gly), cosmic curated COSV10813, ExAC rs747841241, TOPMed rs747841241, gnomAD rs747841241
- R35Q (p.Arg35Gln), ExAC rs763689078, TOPMed rs763689078, gnomAD rs763689078, REVEL 0.51, CADD 24.40
- F37L (p.Phe37Leu), TOPMed rs1170273419, gnomAD rs1170273419, REVEL 0.16, CADD 20.40
- L38M (p.Leu38Met), ExAC rs2381003, gnomAD rs2381003
- L38P (p.Leu38Pro), ExAC rs780091659, gnomAD rs780091659
- L38V (p.Leu38Val), rs2381003, UniProt VAR 061343, ExAC rs2381003, gnomAD rs2381003, REVEL 0.39, CADD 23.50
- A39T (p.Ala39Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A39V (p.Ala39Val), cosmic curated COSV53012, gnomAD rs1457558837
- E40* (p.Glu40Ter), ExAC rs2381002, TOPMed rs2381002, gnomAD rs2381002
- E40K (p.Glu40Lys), ExAC rs2381002, TOPMed rs2381002, gnomAD rs2381002, REVEL 0.74, CADD 27.30
- M42I (p.Met42Ile), rs558128835, NCI-TCGA Cosmic COSV9995, cosmic curated COSV99953, 1000Genomes rs558128835, REVEL 0.22, CADD 15.50, Variant assessed as somatic; moderate impact.
- M42T (p.Met42Thr), Ensembl rs2118843013, REVEL 0.27, CADD 22.80
- M42V (p.Met42Val), gnomAD rs1278071704, REVEL 0.31, CADD 8.25
- S43N (p.Ser43Asn), cosmic curated COSV99952, ExAC rs764563140, gnomAD rs764563140
- T44A (p.Thr44Ala), ExAC rs776199160, gnomAD rs776199160, REVEL 0.42, CADD 25.80
- T44P (p.Thr44Pro), ExAC rs776199160, gnomAD rs776199160
- Y45* (p.Tyr45Ter), ExAC rs760196810, gnomAD rs760196810
- Y45C (p.Tyr45Cys), Ensembl rs1564187161
- V46D (p.Val46Asp), gnomAD rs1825740598, REVEL 0.76, CADD 27.20
- V46I (p.Val46Ile), gnomAD rs1333082206, REVEL 0.11, CADD 13.00
- M47I (p.Met47Ile), cosmic curated COSV99952, Ensembl rs1564187118, REVEL 0.15, CADD 23.60
- M47V (p.Met47Val), TOPMed rs1447127817, gnomAD rs1447127817, REVEL 0.18, CADD 22.60
- M48T (p.Met48Thr), gnomAD rs1411612556
- V49I (p.Val49Ile), ExAC rs768771734, gnomAD rs768771734, REVEL 0.12, CADD 20.60
- F50L (p.Phe50Leu), TOPMed rs1824907373, REVEL 0.33, CADD 19.80
- G51C (p.Gly51Cys), 1000Genomes rs575153087, ExAC rs575153087, TOPMed rs575153087, gnomAD rs575153087, REVEL 0.90, CADD 26.40
- G51S (p.Gly51Ser), rs575153087, NCI-TCGA Cosmic COSV5301, cosmic curated COSV53011, 1000Genomes rs575153087, REVEL 0.91, CADD 25.80, Variant assessed as somatic; moderate impact.
- G51V (p.Gly51Val), ExAC rs756610430, gnomAD rs756610430
- L52R (p.Leu52Arg), TOPMed rs1267813063
- L52V (p.Leu52Val), TOPMed rs1196769580
- G53C (p.Gly53Cys), ExAC rs750945114, TOPMed rs750945114, gnomAD rs750945114, REVEL 0.85, CADD 25.10
- G53S (p.Gly53Ser), ExAC rs750945114, TOPMed rs750945114, gnomAD rs750945114, REVEL 0.80, CADD 23.40
- S54P (p.Ser54Pro), TOPMed rs1824905101, REVEL 0.24, CADD 22.30
- V55M (p.Val55Met), 1000Genomes rs538923905, ExAC rs538923905, TOPMed rs538923905, gnomAD rs538923905, REVEL 0.30, CADD 24.40
- A56T (p.Ala56Thr), gnomAD rs1263139303, REVEL 0.87, CADD 25.40
- H57R (p.His57Arg), ExAC rs752210629, TOPMed rs752210629, gnomAD rs752210629, REVEL 0.21, CADD 23.00
- M58K (p.Met58Lys), ExAC rs764813738, gnomAD rs764813738
- M58T (p.Met58Thr), ExAC rs764813738, gnomAD rs764813738
- M58V (p.Met58Val), Ensembl rs1824903393
- V59A (p.Val59Ala), cosmic curated COSV10645, TOPMed rs1209613166, gnomAD rs1209613166
- V59G (p.Val59Gly), TOPMed rs1209613166, gnomAD rs1209613166, REVEL 0.76, CADD 24.20
- V59L (p.Val59Leu), rs4008659, cosmic curated COSV53022, UniProt VAR 067254, 1000Genomes rs4008659, REVEL 0.30, CADD 17.30
- L60V (p.Leu60Val), NCI-TCGA Cosmic COSV5302, cosmic curated COSV53020, Variant assessed as somatic; moderate impact.
- K62* (p.Lys62Ter), gnomAD rs1354514467, CADD 32.00
- K62R (p.Lys62Arg), ExAC rs753629469, gnomAD rs753629469, REVEL 0.02, CADD 1.45
- K62T (p.Lys62Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K63* (p.Lys63Ter), ExAC rs766128992
- K63N (p.Lys63Asn), NCI-TCGA Cosmic COSV5300, Variant assessed as somatic; high impact.
- K63T (p.Lys63Thr), rs4008658, cosmic curated COSV53003, UniProt VAR 061344, 1000Genomes rs4008658, REVEL 0.14, CADD 0.00
- Y64* (p.Tyr64Ter), 1000Genomes rs553316319, ExAC rs553316319, TOPMed rs553316319, gnomAD rs553316319, CADD 22.70
- Y64F (p.Tyr64Phe), cosmic curated COSV10610, ExAC rs199711780, gnomAD rs199711780, REVEL 0.01, CADD 0.06
- Y64H (p.Tyr64His), TOPMed rs1276354660, gnomAD rs1276354660, REVEL 0.02, CADD 0.01
- G65R (p.Gly65Arg), ESP rs368849644, ExAC rs368849644, gnomAD rs368849644, REVEL 0.44, CADD 24.00
- S66I (p.Ser66Ile), TOPMed rs1384802325, gnomAD rs1384802325
- S66N (p.Ser66Asn), TOPMed rs1384802325, gnomAD rs1384802325, REVEL 0.03, CADD 11.40
- L68F (p.Leu68Phe), ExAC rs775905309, gnomAD rs775905309, REVEL 0.12, CADD 23.20
- G69C (p.Gly69Cys), NCI-TCGA Cosmic COSV9995, cosmic curated COSV99951, Variant assessed as somatic; moderate impact.
- V70I (p.Val70Ile), TOPMed rs1824897965
- N71I (p.Asn71Ile), ExAC rs746373896, TOPMed rs746373896, gnomAD rs746373896, REVEL 0.73, CADD 25.20
- N71K (p.Asn71Lys), ExAC rs781616926, gnomAD rs781616926, REVEL 0.70, CADD 23.00
- N71S (p.Asn71Ser), ExAC rs746373896, TOPMed rs746373896, gnomAD rs746373896, REVEL 0.49, CADD 24.00
- N71T (p.Asn71Thr), ExAC rs746373896, TOPMed rs746373896, gnomAD rs746373896, REVEL 0.71, CADD 24.60
- L72W (p.Leu72Trp), ExAC rs757776208, TOPMed rs757776208, gnomAD rs757776208, REVEL 0.58, CADD 23.80
- G73D (p.Gly73Asp), rs1198614474, NCI-TCGA Cosmic COSV5301, cosmic curated COSV53017, gnomAD rs1198614474, REVEL 0.73, CADD 22.30, Variant assessed as somatic; moderate impact.
- G73S (p.Gly73Ser), cosmic curated COSV99953, gnomAD rs1374071314, REVEL 0.47, CADD 21.90
- G75S (p.Gly75Ser), ExAC rs747608427, TOPMed rs747608427, gnomAD rs747608427, REVEL 0.29, CADD 24.80
- G75V (p.Gly75Val), cosmic curated COSV10454, ESP rs140405277, ExAC rs140405277, TOPMed rs140405277, REVEL 0.52, CADD 24.30
- F76L (p.Phe76Leu), 1000Genomes rs536416831, ExAC rs536416831, gnomAD rs536416831, REVEL 0.04, CADD 0.00
- G77R (p.Gly77Arg), ExAC rs766191156, TOPMed rs766191156, gnomAD rs766191156, REVEL 0.27, CADD 24.30
- G77V (p.Gly77Val), cosmic curated COSV53037, Ensembl rs1354676296, REVEL 0.22, CADD 22.80
- V78I (p.Val78Ile), gnomAD rs1270218464, REVEL 0.60, CADD 22.70
- T79A (p.Thr79Ala), gnomAD rs1215848555, REVEL 0.06, CADD 16.20
- T79I (p.Thr79Ile), ExAC rs750256339, TOPMed rs750256339, gnomAD rs750256339, REVEL 0.12, CADD 23.20
- M80I (p.Met80Ile), ExAC rs761869327, gnomAD rs761869327, REVEL 0.31, CADD 12.00
- M80T (p.Met80Thr), ExAC rs767509430, TOPMed rs767509430, gnomAD rs767509430, REVEL 0.70, CADD 22.10
- G81R (p.Gly81Arg), ExAC rs774538753, gnomAD rs774538753
- V82E (p.Val82Glu), ExAC rs763225810, TOPMed rs763225810, gnomAD rs763225810, REVEL 0.26, CADD 23.00
- V82G (p.Val82Gly), cosmic curated COSV99952, ExAC rs763225810, TOPMed rs763225810, gnomAD rs763225810, REVEL 0.24, CADD 22.90
- V82L (p.Val82Leu), ExAC rs764126290, gnomAD rs764126290
- H83Q (p.His83Gln), ESP rs375803801, ExAC rs375803801, TOPMed rs375803801, gnomAD rs375803801, REVEL 0.12, CADD 13.70
- V84G (p.Val84Gly), TOPMed rs1182364775, REVEL 0.56, CADD 22.20
- V84L (p.Val84Leu), 1000Genomes rs567492290, ExAC rs567492290, TOPMed rs567492290, gnomAD rs567492290, REVEL 0.19, CADD 0.00
- V84M (p.Val84Met), cosmic curated COSV53032, 1000Genomes rs567492290, ExAC rs567492290, TOPMed rs567492290, REVEL 0.20, CADD 0.00
- A85T (p.Ala85Thr), gnomAD rs1397868274, REVEL 0.07, CADD 18.80
- A85V (p.Ala85Val), ExAC rs747557155, TOPMed rs747557155, gnomAD rs747557155, REVEL 0.07, CADD 21.80
- G86A (p.Gly86Ala), ExAC rs754511517, gnomAD rs754511517
- G86D (p.Gly86Asp), rs754511517, NCI-TCGA Cosmic COSV9995, ExAC rs754511517, gnomAD rs754511517, Variant assessed as somatic; moderate impact.
- G86S (p.Gly86Ser), Ensembl rs1824887253
- G86V (p.Gly86Val), cosmic curated COSV99953, ExAC rs754511517, gnomAD rs754511517
- R87C (p.Arg87Cys), cosmic curated COSV99952, 1000Genomes rs143391243, ESP rs143391243, ExAC rs143391243, REVEL 0.24, CADD 8.77
- R87H (p.Arg87His), rs371783551, cosmic curated COSV99951, ESP rs371783551, ExAC rs371783551, REVEL 0.17, CADD 9.85, Variant assessed as somatic; moderate impact.
- I88F (p.Ile88Phe), ExAC rs767456180, gnomAD rs767456180, REVEL 0.46, CADD 9.13
- I88L (p.Ile88Leu), ExAC rs767456180, gnomAD rs767456180, REVEL 0.29, CADD 8.17
- I88T (p.Ile88Thr), cosmic curated COSV53032, 1000Genomes rs569224546, ExAC rs569224546, gnomAD rs569224546, REVEL 0.71, CADD 22.70
- I88V (p.Ile88Val), ExAC rs767456180, gnomAD rs767456180
- S89C (p.Ser89Cys), ExAC rs762878686, gnomAD rs762878686
- S89P (p.Ser89Pro), gnomAD rs1198707602, REVEL 0.93, CADD 25.80
- S89Y (p.Ser89Tyr), ExAC rs762878686, gnomAD rs762878686
- G90A (p.Gly90Ala), gnomAD rs1349541243
- A91V (p.Ala91Val), NCI-TCGA TCGA novel, TOPMed rs1824821341, REVEL 0.46, CADD 24.30, Variant assessed as somatic; moderate impact.
- H92N (p.His92Asn), Ensembl rs1824821063
- H92R (p.His92Arg), ExAC rs767970054, gnomAD rs767970054, REVEL 0.95, CADD 24.80
- M93T (p.Met93Thr), rs1243127641, NCI-TCGA Cosmic COSV5301, NCI-TCGA Cosmic COSV9995, cosmic curated COSV99952, REVEL 0.90, CADD 24.40, Variant assessed as somatic; moderate impact.
- M93V (p.Met93Val), ExAC rs762210355, gnomAD rs762210355
- N94N (p.Asn94Asn), rs79202054, []
- A95T (p.Ala95Thr), ESP rs374393354, ExAC rs374393354, TOPMed rs374393354, gnomAD rs374393354, REVEL 0.07, CADD 16.70
- A96G (p.Ala96Gly), TOPMed rs1238821337
- A96T (p.Ala96Thr), rs776307581, []
- V97M (p.Val97Met), ExAC rs759061075, gnomAD rs759061075, REVEL 0.57, CADD 19.20
- T98A (p.Thr98Ala), ExAC rs776307581, gnomAD rs776307581
- T98S (p.Thr98Ser), ExAC rs770671678, TOPMed rs770671678, gnomAD rs770671678, REVEL 0.17, CADD 17.20
- F99L (p.Phe99Leu), TOPMed rs941138025, gnomAD rs941138025, REVEL 0.29, CADD 17.70
- F99S (p.Phe99Ser), Ensembl rs1824817007, REVEL 0.89, CADD 25.00
- F99V (p.Phe99Val), TOPMed rs941138025, gnomAD rs941138025
- A100S (p.Ala100Ser), 1000Genomes rs77962308, ExAC rs77962308, gnomAD rs77962308, REVEL 0.31, CADD 0.26
- A100T (p.Ala100Thr), cosmic curated COSV53003, 1000Genomes rs77962308, ExAC rs77962308, gnomAD rs77962308, REVEL 0.37, CADD 0.05
- C102S (p.Cys102Ser), gnomAD rs1468629772, REVEL 0.48, CADD 24.40
- C102Y (p.Cys102Tyr), gnomAD rs1468629772, REVEL 0.51, CADD 25.80
- A103T (p.Ala103Thr), gnomAD rs1256940846, REVEL 0.25, CADD 11.20
- A103V (p.Ala103Val), 1000Genomes rs140976103, ESP rs140976103, TOPMed rs140976103, gnomAD rs140976103, REVEL 0.19, CADD 9.73
- G105D (p.Gly105Asp), NCI-TCGA Cosmic COSV9995, cosmic curated COSV99952, Variant assessed as somatic; moderate impact.
- G105V (p.Gly105Val), gnomAD rs1298308230
- R106C (p.Arg106Cys), ExAC rs778763120, TOPMed rs778763120, gnomAD rs778763120, REVEL 0.46, CADD 22.90
- R106H (p.Arg106His), cosmic curated COSV10942, 1000Genomes rs140411243, ExAC rs140411243, TOPMed rs140411243, REVEL 0.25, CADD 14.80
- R106L (p.Arg106Leu), 1000Genomes rs140411243, ExAC rs140411243, TOPMed rs140411243, gnomAD rs140411243
- R106S (p.Arg106Ser), ExAC rs778763120, TOPMed rs778763120, gnomAD rs778763120, REVEL 0.45, CADD 22.30
- V107A (p.Val107Ala), TOPMed rs1324502794, REVEL 0.31, CADD 14.20
- V107L (p.Val107Leu), 1000Genomes rs142586635, ESP rs142586635, ExAC rs142586635, TOPMed rs142586635, REVEL 0.24, CADD 0.03
- V107M (p.Val107Met), 1000Genomes rs142586635, ESP rs142586635, ExAC rs142586635, TOPMed rs142586635, REVEL 0.21, CADD 0.08
- P108A (p.Pro108Ala), ExAC rs750711308, TOPMed rs750711308, gnomAD rs750711308, REVEL 0.09, CADD 0.95
Public AQP7 analysis runs
- AQP7 analysis run — AQP7 (744 variants) — completed 2026-08-20